secwatch.observer — SEC 8-K summary
======================================

Issuer:     SOLENO THERAPEUTICS INC (SLNO)
CIK:        0001484565
Form:       8-K
Filed at:   2026-02-26T23:59:59+00:00
Accession:  0001193125-26-073209
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Soleno Therapeutics appoints Jennifer Fulk as CFO, succeeding retiring James Mackaness
--------------------------------------------------------------------------------

- Jennifer Fulk appointed CFO effective March 2, 2026; base salary $525k, target bonus 45%, option for 67,660 shares, RSUs for 39,200 shares.
- James Mackaness retiring by end of March 2026, will consult through December 2026 for smooth transition.
- Fulk brings 20+ years experience including 15 years at Eli Lilly, most recently CFO/COO at 120Water and CFO at Talkspace.
- Fulk will participate in Soleno's Key Executive Change in Control and Severance Plan.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1484565/000119312526073209/0001193125-26-073209-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1484565/000119312526073209/d110816d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-073209

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer